Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 22, Issue 4, 1997, Pages 295-304

  Li, Yan ^a   Li, Ning Yuan ^b   Sellers, Edward M ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Coumarin 7 hydroxylation; CYP2A6; Human; Microsomes; Monkey

Indexed keywords

ALPHA NAPHTHOFLAVONE; ANTIBODY; COUMARIN; CYTOCHROME P450; KETOCONAZOLE; METHOXSALEN; NICOTINE; ORPHENADRINE; PILOCARPINE; QUINIDINE; SULFAPHENAZOLE;

ADULT; ANIMAL CELL; CERCOPITHECIDAE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROXYLATION; LIVER MICROSOME; MALE; MICHAELIS CONSTANT; NONHUMAN;

EID: 0031424015     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190960     Document Type: Conference Paper

References (26)

1. Cashman J.R., Park S.B., Yang Z-C., Wrighton S.A., Jacob III P., Benowitz N.L. (1992) : Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide. Chem. Res. Toxicol., 5, 639-646.
2. McCracken N.W., Cholerton S., Idle J.R. (1992) : Cotinine formation by cDNA-expressed human cytochrome P450. Med. Sci. Res., 20, 877-878.
3. Messina E.S., Tyndale R.F., Sellers E.M. (1997) : A major role. for CYP2A6 in nicotine C-oxidation by human liver microsome. J. Pharmacol. Exp. Ther., In press.
4. Fernandez-Salguero P., Gonzalez F.J. (1995) : The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics, 5, S123-S128.
5. Yamano S., Tatsuno J., Gonzalez F.J. (1990) : The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry, 29, 1322-1329.
6. Miles J.S., McLaren A.W., Forrester L.M., Glancey M.J., Lang M.A., Wolf C.R. (1990) : Identification of the human liver cytochrome P450 responsible for coumarin 7-hydroxylase activity. Biochem. J., 267, 365-371.
7. Yun C-H., Shimada T., Guengerich F.P. (1991) : Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol. Pharmacol., 40, 679-685.
8. Dalet-Beluche I., Boulenc X., Fabre G., Maurel P., Bonfils C. (1992) : Purification of two cytochrome P450 isozymes related to CYP2A and CYP3A heme families from monkey (baboon, Papio papio) liver microsomes. Cross reactivity with human forms. Eur. J. Biochem., 204, 641-648.
9. Pearce R., Greenway D., Parkinson A. (1992) : Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch. Biochem. Biophys., 298, 211-225.
10. Pelkonen O., Sotaniemi E.A., Ahokas J.T. (1985) : Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. Br. J. Clin. Pharmacol., 19, 59-66.
11. 14C] coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans. Fed. Chem. Toxicol., 30, 105-115.
12. Stevens J.C., Shipley L.A., Cashman J.R., Vandenbranden M., Wrighton S.A. (1993) : Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. Drug Metab. Dispos., 21, 753-760.
13. Steensma A., Beamand J.A., Walters D.G., Price R.J., Lake B.G. (1994) : Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea pig, cynomolgus monkey and human precision-cut liver slices. Xenobiotica, 24, 893-907.
14. Sharer J.E., Shipley L.A., Vandenbranden M.R., Binkley S.N., Wrighton S.A. (1995) : Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey and cynomolgus monkey. Drug Metab. Dispos., 23, 1231-1241.
15. Ohmori S. Horie T., Guengerich F.P., Kiuchi M., Kitada M. (1993) : Purification and characterization of two forms of hepatic microsomal cytochrome P450 from untreated cynomolgus monkeys. Arch. Biochem. Biophys., 305, 405-413.
16. Bourne M., Meunier V., Berger Y., Fahre G., (1996) : Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J. Pharmacol. Exp. Ther., 277, 321-332.
17. Draper A.J., Madan A., Parkinson A. (1997) : Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch. Biochem. Biophys., 341, 47-61.
18. Maenpaa J., Sigusch H., Raunio H. et al. (1993) : Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem. Pharmacol., 45, 1035-1042.
19. Chang T.K.H., Gonzalez F.J., Waxman D.J. (1994) : Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithio-carbamate as selective chemical probes for inhibition of human cytochromes P450. Arch. Biochem. Biophys., 311, 437-442.
20. Guengerich F.P. (1995). Human cytochrome P450 enzymes. In: Ortiz de Montellano, Paul R. (eds) Cytochrome P450: Structure, Mechanism, and Biochemistry. New York: Plenum, 473-535.
21. Lake B.C., Sauer M.J., Esclangon F., Beamand J.A., Price R.J., Walters D.G. (1995) : Metabolism of coumarin by precision-cut calf liver slices and calf liver microsomes. Xenobiotica, 25, 133-141.
22. Maenpaa J., Juvonen R., Raunio H., Rautio A., Pelkonen O. (1994) : Metabolic interactions of methoxsalen and coumarin in humans and mice. 48, 1363-1369.
23. Raunio H., Syngelma T., Pasanen M. et al. (1988) : Immunochemical and catalytic studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem. Pharmacol., 37, 3889-3895.
24. Kimonen T., Juvonen R. O., Alhava E., Pasanen M. (1995) : The inhibition of CYP enzymes in mouse and human liver by pilocarpine. Br. J. Pharmacol., 114, 832-836.
25. Nakajima M., Yamamoto T., Nunoya K-I. et al. (1996) : Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J. Pharmacol. Exp. Ther.,: 277, 1010-1015.
26. Nakajima M., Yamamoto T., Nunoya K-I. et al. (1996): Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab. Dispos., 24, 1212-1217.